AJ, The cash costs will probably be around $800 to $900 (Apex accounting) again but if they make any money for the quarter is another thing.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025